标题（英文）

A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases

分类

基因治疗

分类韩

유전자치료제

国家

西班牙

国家韩

스페인

条件

Epstein-Barr Virus (EBV)-Associated Diseases|EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD)|EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (AID LPD)|EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (CNS PTLD)|EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD)|Solid Organ Transplant Complications|Lymphoproliferative Disorders|Allogeneic Hematopoietic Cell Transplant|Stem Cell Transplant Complications|EBV+ Sarcomas|Leiomyosarcoma|Chronic Active Epstein-Barr Virus (CAEBV)|Chronic Active Epstein-Barr Virus With Hemophagocytic Lymphohistiocytosis (HLH)|Lymphohistiocytosis, Hemophagocytic

干预

Biological: Tabelecleucel

阶段

Phase 2